Heman Lapman Chao
Director/Miembro de la Junta en Helix Immuno-Oncology SA .
Perfil
Heman Lapman Chao is a Member-Supervisory Board at Helix Immuno-Oncology SA. He previously worked as Director, Chief Executive & Scientific Officer at Helix BioPharma Corp.
from 2017 to 2021.
Prior to that, he was the President of Sensium Technologies, Inc. from 2004 to 2008 and a Manager from 1999 to 2002.
Dr. Chao earned a doctorate degree from Queen's University in 1994.
Cargos activos de Heman Lapman Chao
| Empresas | Cargo | Inicio |
|---|---|---|
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Heman Lapman Chao.
| Empresas | Cargo | Fin |
|---|---|---|
| HELIX BIOPHARMA CORP. | Director Ejecutivo | 01/09/2021 |
Sensium Technologies, Inc.
 Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Presidente | 01/04/2008 |
Sensium Technologies, Inc.
Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Corporate Officer/Principal | 01/06/2002 |
Formación de Heman Lapman Chao.
| Queen's University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HELIX BIOPHARMA CORP. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Sensium Technologies, Inc.
Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Commercial Services |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |
- Bolsa de valores
- Insiders
- Heman Lapman Chao
